Analytical Data
-
基因名
ST7
- Application
-
别名
Suppressor of tumorigenicity 7 protein. Protein FAM4A1. Protein HELG
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9NRC1
-
表达区间
1-547 aa
-
氨基酸序列
MAEAATGFLEQLKSCIVWSWTYLWTVWFFIVLFLVYILRVPLKINDNLSTVSMFLNTLTPKFYVALTGTSSLISGLILIFEWWYFRKYGTSFIEQVSVSHLRPLLGGVDNNSSNNSDSNRQSVSECKVWRNPLNLFRGAEYNRYTWVTGREPLTYYDMNLSAQDHQTFFTCDSDHLRPADAIMQKAWRERNPQARISAAHEALEINECATAYILLAEEEATTIAEAEKLFKQALKAGDGCYRRSQQLQHHGSQYEAQHRRDTNVLVYIKRRLAMCARRLGRTREAVKMMRDLMKEFPLLSMFNIHENLLEALLELQAYADVQAVLAKYDDISLPKSATICYTAALLKARAVSDKFSPEAASRRGLSTAEMNAVEAIHRAVEFNPHVPKYLLEMKSLILPPEHILKRGDSEAIAYAFFHLAHWKRVEGALNLLHCTWEGTFRMIPYPLEKGHLFYPYPICTETADRELLPSFHEVSVYPKKELPFFILFTAGLCSFTAMLALLTHQFPELMGVFAKAFLSTLFAPLNFVMEKVESILPSSLWHQLTRI
-
分子量
89.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ST7, a novel protein implicated in tumor suppression and cellular signaling, has garnered significant attention in recent years due to its potential role in cancer biology. Originally identified through genetic studies, ST7 displays unique characteristics that distinguish it from other members of the tumor suppressor gene family. Research has indicated that ST7 may be involved in various cellular processes, including apoptosis, the regulation of cell proliferation, and the modulation of immune responses. Its expression levels and functional interactions have been observed to vary in different cancer types, suggesting a complex role in tumorigenesis and disease progression. Furthermore, understanding the molecular mechanisms by which ST7 exerts its effects could provide insight into potential therapeutic targets for cancer treatment. Recent advancements in recombinant protein technology have enabled the production of ST7 in laboratory settings, allowing for in-depth studies of its structure, function, and interactions with other cellular components. This research not only helps clarify the biological significance of ST7 but also paves the way for potential applications in biomarker discovery and targeted therapies in oncology. The ongoing exploration of ST7’s role in cancer progression underscores the importance of continuing to investigate its biochemical pathways and therapeutic implications.
